Morepen Laboratories Limited — Board Meeting, 06-08-2025: Outcome of Board Meeting

Morepen Labs' board met on August 6, approving consolidated financial results for Q1 FY26 with a net profit of Rs 10.75 Cr. A key strategic update: the company's stake in Dr. Morepen Ltd (DML) dropped from 80% to 19.94% due to share sales and DML's equity issuance for acquiring Groom Town. This changes DML's operational status. They set August 30 as the record date for the FY25 final dividend and extended the Medical Devices Business hiving-off plan. Mr. Sanjay Suri was re-appointed as Whole-Time Director. The 40th AGM is on September 6.